• RadNet unit DeepHealth reported study results indicating its Prostate MR Solution AI could have avoided 149 prostate biopsies, or 18.9%.
• Study protocol kept 98.4% sensitivity for detecting clinically significant prostate cancer in a cohort of 787 men.
• Analysis covered retrospective prostate MRI exams from 2014-2025 across Germany, the Netherlands, and the US.
• DeepHealth positioned the findings as support for AI-assisted biopsy decisions when MRI assessments are uncertain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RadNet Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080600PRIMZONEFULLFEED9841206) on October 08, 2026, and is solely responsible for the information contained therein.